FIELD: medicine.
SUBSTANCE: invention represents a mixture of two structural isomers: 2,6-di(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)-4-methylphenol and its diastereomers, and 2-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)-6-(2,2,1-trimethylbicyclo[2.2.1]hept-5-yl)-4-methylphenol, and their diastereomers with the ratio of the first and second structural isomers from 60:40 wt % to 95:5 wt %.
EFFECT: extension of the arsenal of means, possessing simultaneously haemorheological, anti-aggregate, anti-thrombogenic, retinoprotecting, endothelium-protecting, neuroprotecting, anti-arrhythmia and anti-ischemic activity, enhancing the cerebral blood flow.
4 dwg, 20 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
| AGENT RELIEVING POSTINFARCTION MYOCARDIAL REMODELING | 2020 |
|
RU2740895C1 |
| ANTI-ISCHEMIC DRUG | 2012 |
|
RU2499593C1 |
| MEANS FOR CEREBRAL BLOOD FLOW INCREASE | 2016 |
|
RU2655810C2 |
| AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
| USING SECOISOLARICIRESINOL AS HAEMORHEOLOGICAL, ANTI-PLATELET AND ENDOTHELIUM-PROTECTIVE AGENT | 2013 |
|
RU2532356C1 |
| AGENT IMPROVING RHEOLOGICAL PROPERTIES OF BLOOD | 2013 |
|
RU2546297C1 |
| REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
| AGENTS WITH HEMORHEOLOGICAL, ANTIAGGREGANT AND ANTITROMBOGENIC ACTIVITY | 2007 |
|
RU2347561C2 |
| NOVEL DERIVATIVES OF 2,6-DI-ISOBORNYL PHENOL AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2516699C2 |
